Baoping Cao

#28 Fuxing Road
Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.

First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.

Journal: BMC cancer

Published: November 15, 2022

Integrative analysis of the association between circadian rhythm and lupus nephritis.

Integrative analysis of the association between circadian rhythm and lupus nephritis.

Journal: Clinical kidney journal

Published: October 31, 2022

Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor Prognosis of Diffuse Large B-cell Lymphoma.

Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor Prognosis of Diffuse Large B-cell Lymphoma.

Journal: Discovery medicine

Published: October 24, 2022

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.

Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.

Journal: Aging

Published: January 30, 2021

Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: March 27, 2017

Systematic study of novel lncRNAs in different gastrointestinal cancer cells.

Systematic study of novel lncRNAs in different gastrointestinal cancer cells.

Journal: Discovery medicine

Published: April 27, 2016

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.

Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 02, 2015

The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.

The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.

Journal: Clinical epigenetics

Published: November 03, 2015

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.

Methylation of DACT2 accelerates esophageal cancer development by activating Wnt signaling.

Journal: Oncotarget

Published: August 14, 2015

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.

Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer.

Journal: Oncotarget

Published: April 23, 2015

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker.

Journal: Genes & cancer

Published: April 09, 2015

Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.

Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth.

Journal: Oncotarget

Published: February 27, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026